Combineren van gerichte radionuclide therapie en kanker immuun therapie om precisie geneeskunde te bevorderen door innovatie.
SRP-Groeifinanciering: Single-domain antibody fragment (SdAb)-based TArgeted Radionuclide Therapy: STaRT programme
Moleculaire beeldvorming van HER2 expressie bij borstcarcinoom door middel van radioactief gemerkte Nanobodies.
Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging
Site-specific fluorescent labeling, single-step immunocytochemistry, and delivery of nanobodies into living cells
Near-native, site-specific and purification-free protein labeling for quantitative protein interaction analysis by MicroScale Thermophoresis
Site-specific labeling of 'second generation' annexin V with Tc-99m(CO)(3) for improved imaging of apoptosis in vivo